NCT07227402 2026-04-13
LITESPARK-033
Merck Sharp & Dohme LLC
Phase 3 Recruiting
Clinical Trials
15 trialsNCT06661720 2026-04-07
STRIKE
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT06500455 2026-04-03
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
NRG Oncology
Phase 3 Recruiting
NCT07197580 2026-04-01
LUTEON
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3 Recruiting
NCT07405164 2026-03-31
MK-6482-043
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT05738694 2026-03-17
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Sun Yat-sen University
Phase 3 Recruiting
NCT07092566 2026-01-20
R.E.C.K vs Exparel in Robotic Nephrectomy
Wake Forest University Health Sciences
Phase 3 Recruiting
NCT06726421 2026-01-15
STROKER
Sun Yat-sen University
Phase 3 Recruiting
NCT04510597 2025-09-09
PROBE
SWOG Cancer Research Network
Phase 3 Recruiting
NCT05796973 2025-06-27
MOVES
Tampere University Hospital
Phase 3 Recruiting
NCT05078047 2025-06-05
MOIO
UNICANCER
Phase 3 Recruiting
NCT03592472 2025-04-13
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Xynomic Pharmaceuticals, Inc.
Phase 3 Recruiting
NCT06364631 2025-01-16
CARE1
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Recruiting
NCT06750419 2024-12-27
89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3 Recruiting
NCT03288532 2020-09-07
RAMPART
University College, London
Phase 3 Recruiting